Product Information
HYDROMORPHONE 4 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.2192 per EA under NDC 13107010801. Its NADAC has been published 521 times since Oct 12, 2016.
FDA first approved this application on May 13, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107010801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205814FDA Approved
5/13/2016
TE Code
AB
On Market Since
5/17/2016
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE 4 MG TABLET has been published 521 times since Oct 12, 2016, and over the history we have for it it has risen 114.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2192 per EA |
|---|---|
| All-time high | $0.2194 (Aug 12, 2026) |
| All-time low | $0.0822 (Apr 17, 2019) |
| 52-week high | $0.2194 |
| 52-week low | $0.1909 |
| Median price | $0.0944 |
| Average price | $0.1161 |
| Largest weekly change | +52.1% (Aug 21, 2024) |
| Weeks tracked | 521 |
| Tracking since | Oct 12, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the HYDROMORPHONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurolife Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HYDROMORPHONE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROMORPHONE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE 4 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.2192 per EA (NDC 13107010801), effective Sep 30, 2026.
How has the price of HYDROMORPHONE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE 4 MG TABLET has risen 114.7%. It has been tracked across 521 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE 4 MG TABLET?
Since Oct 12, 2016, the NADAC for HYDROMORPHONE 4 MG TABLET has ranged from a low of $0.0822 (Apr 17, 2019) to a high of $0.2194 (Aug 12, 2026), with a median of $0.0944 per EA.
Are there cheaper alternatives to HYDROMORPHONE 4 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of HYDROMORPHONE 4 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROMORPHONE 4 MG TABLET?
HYDROMORPHONE 4 MG TABLET (NDC 13107010801) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.